Kutrase

— THERAPEUTIC CATEGORIES —
  • Digestive and biliary disorders

Kutrase Generic Name & Formulations

General Description

Lipase 1200 Units, amylase 30000 Units, protease 30000 Units; caps.

Pharmacological Class

Digestive enzymes.

How Supplied

Caps—100

Manufacturer

Kutrase Indications

Indications

Symptomatic treatment of digestive dysfunction.

Kutrase Dosage and Administration

Adult

May be opened and sprinkled on food. 1 cap with meals or snacks.

Children

Not recommended.

Kutrase Contraindications

Contraindications

Glaucoma. GI or urinary tract obstruction. Paralytic ileus. Intestinal atony. Unstable cardiovascular status. Severe ulcerative colitis. Toxic megacolon. Myasthenia gravis. Acute pancreatic conditions. Pork allergy.

Kutrase Boxed Warnings

Not Applicable

Kutrase Warnings/Precautions

Warnings/Precautions

High environmental temperature. Diarrhea (may indicate obstruction). Autonomic neuropathy. Hyperthyroidism. Cardiovascular disease (esp. tachycardia). CHF. Arrhythmias. Hypertension. Renal disease. Hiatal hernia associated with reflux esophagitis. Avoid inhaling contents of caps. Pregnancy (Cat.C). Nursing mothers.

Kutrase Pharmacokinetics

See Literature

Kutrase Interactions

Interactions

Avoid concomitant antacids.

Kutrase Adverse Reactions

Adverse Reactions

Drowsiness, dizziness, blurred vision, other anticholinergic effects, suppression of lactation, paradoxical excitement, diarrhea.

Kutrase Clinical Trials

See Literature

Kutrase Note

Not Applicable

Kutrase Patient Counseling

See Literature